Lanzamiento Enero 2027

Ensayo controlado aleatorizado2014Financiación no declarada

Fish Oil (SMOFlipid) and olive oil lipid (Clinoleic) in very preterm neonates

Deshpande G, Simmer K, Deshmukh M, Mori TA, Croft KD, Kristensen J

Journal of pediatric gastroenterology and nutrition · 59 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2013-09-17 · J Pediatr Gastroenterol Nutr · vol. 58 · número 2 · págs. 177–182
Editorial
Lippincott Williams & Wilkins
Citado
88 citas · más que el 94% de estudios similares · 4.0× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
35 trabajos
Acceso
De pago
Áreas de investigación
Neonatal Respiratory Health Research · Infant Nutrition and Health · Clinical Nutrition and Gastroenterology
Palabras clave
Docosahexaenoic acid, Fish oil, Polyunsaturated fatty acid, Eicosapentaenoic acid, Soybean oil, Medicine, Food science, Linoleic acid, Fatty acid, Lipid peroxidation, Internal medicine, Biochemistry, Oxidative stress, Chemistry, Biology, Fishery, Fish <Actinopterygii>
MeSH
humans, vitamin e, docosahexaenoic acids, eicosapentaenoic acid, soybean oil, fat emulsions, intravenous, fatty acids, unsaturated, f2-isoprostanes, linoleic acid, oleic acid, fish oils, plant oils, parenteral nutrition, total, lipid peroxidation, oxidative stress, infant, newborn, female, male, infant, extremely premature, olive oil, coconut oil

6 autores

  • Girish C. Deshpande🇦🇺 · autor de correspondenciaKing Edward Memorial Hospital
  • Karen Norrie Simmer🇦🇺 · autor de correspondenciaKing Edward Memorial Hospital
  • Mangesh Deshmukh🇦🇺 · autor de correspondenciaKing Edward Memorial Hospital
  • Trevor Anthony Mori🇦🇺The University of Western Australia
  • Kevin D. Croft🇦🇺The University of Western Australia
  • Judy Kristensen🇦🇺King Edward Memorial Hospital

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objectives

Fat emulsions used in Australia for parenteral nutrition in preterm neonates have been based on either soybean oil or olive oil (OO). OO lipid Clinoleic has a high ratio of n-6 to n-3 fatty acids (9:1); this may not be ideal for long-chain polyunsaturated fatty acids supply. Newly available SMOFlipid has an appropriate ratio of n-6 to n-3 fatty acids (2.5:1). SMOFlipid also contains OO (25%), coconut oil (30%), and soybean oil (30%). The aims of the study were to evaluate the safety of the SMOFlipid and to test the hypothesis that SMOFlipid would lead to increased omega-3 long-chain polyunsaturated fatty acid levels and reduced oxidative stress as compared with Clinoleic in preterm neonates (<30 weeks).

Methods

Preterm neonates (23-30 weeks) were randomised to receive Clinoleic or SMOFlipid emulsion for 7 days. Investigators and outcome assessors were masked to allocation. Plasma F2-isoprostanes (lipid peroxidation marker), red blood cell fatty acids, and vitamin E were measured before and after the study. Blood culture positive sepsis and growth were monitored for safety.

Results

Thirty of 34 participants completed the study. Both emulsions were well tolerated without any adverse events. F2-isoprostane levels were reduced in the SMOFlipid group as compared with baseline. Eicosapentanoic acid and vitamin E levels were significantly increased in the SMOFlipid group. Oleic acid and linoleic acid levels were increased in both groups. No significant differences were noted in poststudy docosahexaenoic acid levels in both groups despite higher levels of docosahexaenoic acid in SMOFlipid.

Conclusions

SMOFlipid was safe, well tolerated, and showed beneficial effect in terms of reduction of oxidative stress by reducing lipid peroxidation levels in high-risk preterm neonates.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.